Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus

Medical Science Monitor

Volumn 15, Issue 6, 2009, Pages

  Pflueger, Axel ^a   Abramowitz, David ^a   Calvin, Andrew D ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Acute renal failure; Contrast media; Contrast nephropathy; Diabetic nephropathy; Iodinated contrast agent

Indexed keywords

2 (2 HYDROXYETHYL) 1 [3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL)ACRYLOYL]PIPERIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; BICARBONATE; BW A1433U; CONTRAST MEDIUM; CREATININE; DIATRIZOATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FR 113452; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODIXANOL; IOHEXOL; IOPAMIDOL; IOTROLAN; METFORMIN; NAXIFYLLINE; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; THEOPHYLLINE; UNCLASSIFIED DRUG;

CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; DEHYDRATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYDRATION; HYPOTENSION; KIDNEY ISCHEMIA; NEPHROTOXICITY; OPERATION DURATION; OSMOLALITY; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; SEIZURE; SEPSIS; SHOCK; TACHYCARDIA; VASOCONSTRICTION;

CONTRAST MEDIA; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY DISEASES; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 66849091772     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Weisbord SD et al: Prevention, Incidence, and Outcomes of Contrast- Induced Acute Kidney Injury. Arch Intern Med, 2008; 168, 1325-1332
2. Barrett BJ: Metaanalysis of the Relative Nephrotoxicity of High- and Low-Osmolality lodinated Contrast Media. Radiology, 1993; 188, 171-178 (Pubitemid 23183119)
3. Barrett BJ, Vavasour HM, McDonald J et al: Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney International, 1992; 41, 1274-1279
4. Pflueger A et al: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clinic Proceedings, 2000; 75, 1275-1283
5. Rudnick MR, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens, 1996; 5: 127-133 (Pubitemid 26162160)
6. Rudnick MR: Contrast-Induced Nephropathy: What Are the True Clinical Consequences? Clin J Am Soc Nephrol, 2008; 3, 263-272
7. Rudnick MR, Tumlin J: Contrast-Induced Nephropathy: Is the Picture any Clearer? Clin J Am Soc Nephrol, 2008; 3: 261-262
8. From AM, Williams AW, Cha SS et al: Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol, 2008; 3(1): 10-18
9. From AM, Bartholmai BJ, Williams AW et al: Mortality Associated With Nephropathy After Radiographic Contrast Exposure. Mayo Clin Proc, 2008; 83: 1095-1100
10. Kane G et al: Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant, 2008; 23: 1233-1240
11. Reed PS, Boura JA, O'Neill WW, Kahn JK: Comparison of the Usefulness of Gadodiamide and Iodine Mixture Versus Iodinated Contrast Alone for Prevention of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography. Am J Cardiol, 2007; 100: 1090-1093 (Pubitemid 47404463)
12. Idée J-M et al: Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review. Toxicology, 2008; 248: 77-88
13. Broome D: Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting. Eur J Radiol Electronic publication, 2008
14. Harkonen S: Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med, 1977; 63: 939-946 (Pubitemid 8251836)
15. Harnish PP, Ebrahimi R: Iodixanol. Experience in 1,259 patients in the United States. Invest Radiol, 1994; 29: 236-237
16. Manske CL, Strony JT, Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med, 1990; 89, 615-620 (Pubitemid 20384319)
17. Morcos SK: Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol, 1998; 71: 157-165
18. Al-Ghonaim MPN: Prevention and Treatment of Contrast-Induce Nephropathy. Tech Vasc Interventional Rad, 2006; 9: 42-49
19. Rudnick MRGS, Wexler L, Ludbrook PA et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney International, 1995; 47: 254-261
20. Persson PB, Liss P: Pathophysiology of contrast medium-induced nephropathy. Kid Int, 2005; 68: 14-22 (Pubitemid 43181360)
21. Liss P, Hansell P, Lagerqvist B: Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kid Int, 2006; 70: 1811-1817 (Pubitemid 44684813)
22. Aspelin P, Fransson SG, Strasser R et al: Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. NEJM, 2003; 348: 491-499
23. Chalmers N: Comparison of iodixanol and iohexol in renal impairment. [Clinical Trial. Comparative Study. Journal Article. Randomized Controlled Trial]. Br J Radiol, 1999; 72: 701-703 (Pubitemid 29355616)
24. Solomon R: The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney International, 2005; 68, 2256-2263 (Pubitemid 43117802)
25. Voeltz MD, McDaniel MC, Manoukian SV: The Important Properties of Contrast Media: Focus on Viscosity. J Invasive Cardiol, 2007; 19: 1A-9A
26. Kuhn M et al: The PREDICT Study: A Randomized Double-Blind Comparison of Contrast-Induced Nephropathy After Low- or Isoosmolar Contrast Agent Exposure. AJR, 2008; 191: 151-157
27. Thomsen H et al: The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol -400 and Iodixanol-320 in Patients With Chronic Kidney Disease Undergoing Abdominal Computed Tomography. Invest Radiol, 2008; 43: 170-178
28. Solomon RJ, Doucet S, Sharma AK et al: Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease. Circulation, 2007; 115: 3189-3196 (Pubitemid 47012233)
29. Harjai KJ, Shenoy C, Sattur S et al: A Comparison of Contemporary Definitions of Contrast Nephropathy in Patients Undergoing Percutaneous Coronary Intervention and a Proposal for a Novel Nephropathy Grading System. Am J Cardiol, 2008; 101: 812-819
30. Bellomo R et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care, 2004; 8: R204-12
31. Mehta R et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007; 11(R31): 3-8 (Pubitemid 46604959)
32. Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int, 2007; 73: 538-546
33. Bell M et al: Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant, 2005; 20: 354-360 (Pubitemid 40276892)
34. Åhlström A et al: Comparison of 2 Acute Renal Failure Severity Scores to General Scoring Systems in the Critically Ill. Am J Kidney Dis, 2006; 48: 262-268 (Pubitemid 44069614)
35. Hoste E et al: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Critical Care, 2006; 10: R73 (Pubitemid 43982486)
36. Abosaif NY, Tolba YA, Heap M et al: The Outcome of Acute Renal Failure in the Intensive Care Unit According to RIFLE: Model Application, Sensitivity, and Predictability. Am J Kidney Dis, 2005; 46: 1038-1048 (Pubitemid 41690229)
37. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettilä V: Acute Renal Failure After Cardiac Surgery: Evaluation of the RIFLE Classification. Ann Thorac Surg, 2006; 81: 542-546 (Pubitemid 43120552)
38. Uchino S, Bellomo R, Goldsmith D et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med, 2006; 34: 1913-1917 (Pubitemid 43982467)
39. Bellomo R, Ronco C, Kellum J et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care, 2004; 8: 204-212
40. Gruberg L, Mintz G, Mehran R et al: The Prognostic Implications of Further Renal Function Deterioration Within 48h of Interventional Coronary Procedures in Patients With Pre-existent Chronic Renal Insufficiency. J Am Coll Cardiol, 2000; 36: 1542-1548
41. Gruberg L, Dangas G, Mintz GS et al: Acute Renal Failure Requiring Dialysis After Percutaneous Coronary Interventions. Catheter Cardiovasc Interv, 2001; 52: 409-416 (Pubitemid 32275026)
42. Kowalczyk J, Kowalski O, Swiatkowski A et al: Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol, 2007; 65(6): 635-643 (Pubitemid 47358800)
43. Rihal CS, Grill DE, Berger PB et al: Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention. Circulation, 2002; 105: 2259-2264 (Pubitemid 34535335)
44. Iakovou I, Mehran R, Lansky AJ et al: Impact of Gender on the Incidence and Outcome of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention. J Invasive Cardiol, 2003; 15: 18-22 (Pubitemid 36143008)
45. Heyman SN, Kaiser N, Spokes K et al: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol, 1992; 3: 58-65
46. Tumlin J et al: Pathophysiology of Contrast-Induced Nephropathy. Am Journ of Cardio, 2006; 98: 14K-20K (Pubitemid 44292090)
47. Agmon Y, Greenfeld Z, Rosen S, Brezis M: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest, 1994; 94(3): 1069-1075 (Pubitemid 24286448)
48. Arend LJ, Burnett JC Jr, Megerian C, Spielman WS: Role for intrarenal adenosine in the renal hemodynamic response to contrast media. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med, 1987; 110: 406-411
49. Deray G, Cacoub P, Baumelou B et al: A role for adenosine and calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol, 1990; 10: 316-322 (Pubitemid 20317743)
50. Yuan Z, Li S: Role of increased cytosolic calcium in rabbit proximal tubule cell injury induced by diatrizoate and protection by chlorpromazine.. Program and abstracts of the XII International Congress of Nephrology; June 18, 1993; Jerusalem, Israel. Abstract 279, 1993
51. Idée J, Bonnemain B: Reliability of experimental models of iodinated contrast media-induced acute renal failure. From methodological considerations to pathophysiology. Invest Radiol, 1996; 31: 230-241
52. McCoy DE, Olson BA, Levier DG et al: The renal adenosine system: structure, function, and regulation. Semin Nephrol, 1993; 13: 31-40 (Pubitemid 23020239)
53. Pflueger AC, Osswald H: Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am J Physiol, 1995; 269(4 Pt 2): F529-35
54. Heyman SN, Rosenberger C: Renal Parenchymal Hypoxia, Hypoxia Adaptation, and the Pathogenesis of Radiocontrast Nephropathy. Clin J Am Soc Nephrol, 2008; 3: 288-296
55. Pflueger AC, Knox FG: Effect of renal interstitial adenosine infusion on phosphate excretion in diabetes mellitus rats. Am J Physiol, 1998; 274: R1228-35 (Pubitemid 28255822)
56. Pflueger AC, Knox FG: Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide. Am J Physiol, 1999; 276: F340-46 (Pubitemid 29157526)
57. Osswald H: In Regulatory Function of Adenosine: Berne RM, Rubio R (eds.), Martinus Nijhof Publishers, The Hague, Netherlands, 1983; 399-415
58. th Edition. 1680-1711 (WB Saunders Co, Philadelphia, Pa, 1996)
59. nd Edition. Davison AM, C. J., Grünfeld J-P, Kerr DNS, Ritz E, Winearls CG) 93-132 (Oxford University Press, New York, 1998)
60. Gould J, Sivaprasadarao A, Bowmer CJ, Yates MS: Renal adenosine A1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the rat. Br J Pharmacol, 1997; 120: 947-953 (Pubitemid 27122737)
61. Erley CM, Schlepckow S, Koehler J et al: Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int, 1994; 45: 1425-1431 (Pubitemid 24135030)
62. Erley CM, Rehfuss D, Scholtes B et al: Prevention of radiocontrast-media- induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrology Dialysis Transplantation, 1999; 14: 1146-1149 (Pubitemid 29209299)
63. Katholi RE, McCann WP, Woods WT Jr et al: Nephrotoxicity from contrast media: attenuation with theophylline. Radiology, 1995; 195(1): 17-22
64. Kolonko A, Kokot F: The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents. J Nephrol, 1998; 11: 151-156 (Pubitemid 28288221)
65. th Edition. Brenner BM. 1680-1711 (WB Saunders Co, Philadelphia, 1996)
66. Ribeiro L et al: Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents. Kidney International, 2004; 65: 589-596 (Pubitemid 38130653)
67. Richardson D, Regino C, Yao H, Johnson J: Methionine oxidation by peroxymonocarbonate, a reactive oxygen species formed from CO2/ bicarbonate and hydrogen peroxide. Free Radic Biol Med, 2003; 15: 1538-1550 (Pubitemid 37532905)
68. Heyman SN, Cantley L, Spokes K et al: Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radio, 1993; 28: 313-318 (Pubitemid 24079685)
69. Tumlin J, Wang A, Murray P, Mathur V: Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J, 2002; 143: 894-903 (Pubitemid 34595351)
70. Scott J, King G: Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci, 2004; 1031: 204-213 (Pubitemid 40361755)
71. Locatelli F et al: Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant, 2003; 18: 1272-1280 (Pubitemid 36826946)
72. Massy Z, Nguyen-Khoa T: Oxidative stress and chronic kidney failure: markers and management. J Nephrol, 2002; 15: 336-341
73. Koya D et al: Effects of Antioxidants in Diabetes-Induced Oxidative Stress in the Glomeruli of Diabetic Rats. Am Soc of Nephr, 2003; 14: S250-53 (Pubitemid 36903935)
74. Lee H, Ha H, King G: Reactive Oxygen Species and Diabetic Nephropathy. Am Soc of Nephr, 2003; 14: S209-10 (Pubitemid 36903926)
75. Lee H, Yu M, Yang Y et al: Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy. Am Soc of Nephr, 2003; 14: S241-45 (Pubitemid 36903933)
76. Li J, Shah A: ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy. Am Soc of Nephr, 2003; 14: S221-26 (Pubitemid 36903929)
77. Hogg N, Griffith O: The biological chemistry of NO. Nitric Oxide and The Kidney, Goligorsky MS, Gross SS, 1997; 3-21
78. Drager L et al: Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant, 2004; 19: 1803-1807 (Pubitemid 38961391)
79. Fiaccadori E et al: Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media. Nephrol Dial Transplant, 2004; 19: 865-869 (Pubitemid 38455657)
80. Sandhu C, Newman D, Morgan R et al: The role of oxygen free radicals in contrast induced nephrotoxicity. Acad Radiol, 2002; 9: S436-37
81. Cetin M et al: Ionic High-Osmolar Contrast Medium Causes Oxidant Stress in Kidney Tissue: Partial Protective Role of Ascorbic Acid. Renal Failure, 2008; 30: 567-572
82. Toprak O et al: Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant, 2008; 23: 853-859
83. James A, Cocheme H, Smith R et al: Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem, 2005; 280: 21295-21312 (Pubitemid 40805692)
84. James A et al: Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem, 2007; 282: 14708-14718 (Pubitemid 47093346)
85. Melin J et al: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int, 1997; 52: 985-991 (Pubitemid 27435831)
86. Control C. o. D. National Diabetes Fact Sheet, 2005
87. http: //www.cdc.gov/diabetes/. Diabetes Facts 2008, 2008
88. Heyman SN, Brezis M: Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol, 1994; 2: 153-157 (Pubitemid 24134044)
89. Weisberg LS, Kurnik BR: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney International, 1994; 45: 259-265 (Pubitemid 24046017)
90. ShafiT, Porush JG, Shapiro WB: Infusion intravenous pyelography and renal function. Effects in patients with chronic renal insufficiency. Arch Intern Med, 1978; 138: 1218-1221
91. Toprak O et al: Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant, 2007; 22: 819-826 (Pubitemid 46351691)
92. th ed., 2000; 1731-1760
93. Thomas M, Weekes A, Broadley O et al: The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust, 2006; 185: 140-144 (Pubitemid 44262796)
94. Rosolowsky E et al: Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract, 2008; 82: S46-53
95. Kanwar YS, Sun L, Xie P et al: Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood), 2008; 233(1): 4-11
96. Dai FX, Skopec J, Diederich D: Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol, 1993; 4: 1327-1336
97. Diederich D: In Nitric Oxide and the Kidney: Physiology and Pathophysiology. Goligorsky MS (eds.), Chapman & Hall, New York, NY, 1997; 349-367
98. Pflueger A, Larson T, Hagl S, Knox F: Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol, 1999; 277: 725-733 (Pubitemid 29458144)
99. Ishimura E et al: Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int, 1997; 51: 1920-1927 (Pubitemid 27252763)
100. Frauchiger B, Nussbaumer P, Hugentobler M, Staub D: Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine. Nephrol Dial Transplant, 2000; 15: 827-832 (Pubitemid 30312001)
101. Epstein F, Veves A, Prasad P: Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care, 2002; 25: 575-578 (Pubitemid 41103356)
102. Solomon R, Mann D, D'Elia J, Silva P: Effects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast Agents. N Engl J Med, 1994; 331(21): 1416-1420 (Pubitemid 24348355)
103. Solomon R, Pilote L, Eisenberg MJ et al: Prevention of Radiocontrast- Induced Renal Insufficiency. N Engl J Med, 1995; 332: 1035-1036
104. Trivedi HS, Nasr S, Aggarwal K et al: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract, 2003; 93: C29-34
105. Weisbord SD: Prevention of Contrast-Induced Nephropathy with Volume Expansion. Clin J Am Soc Nephrol, 2008; 3: 273-280
106. Mueller C et al: Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. Swiss Med Wkly, 2005; 135: 286-290 (Pubitemid 40827288)
107. Merten G et al: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA, 2004; 291: 2328-2334 (Pubitemid 38656299)
108. Brar SS et al: Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial. JAMA, 2008; 300: 1038-1046
109. Maioli M et al: Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography or Intervention. Journ of Am Coll of Cardio, 2008; 52: 735-1097
110. Richardson D, Regino C, Yao H, Johnson J: Methionine oxidation by peroxymonocarbonate, a reactive oxygen species formed from CO2/ bicarbonate and hydrogen peroxide.. Free Radical Biology & Medicine, 2003; 35: 1538-1550 (Pubitemid 37532905)
111. Romano G et al: Contrast agents and renal cell apoptosis. Eur Heart J, 2008; 20: 2569-2576
112. Tepel M, Schwarzfeld C, Laufer U et al: Prevention of radiographic-contrast- agent-induced reductions in renal function by acetylcysteine. N Engl J Med, 2000; 343: 180-184 (Pubitemid 30489215)
113. Fishbane S: N-Acetylcysteine in the Prevention of Contrast-Induced Nephropathy. Clin J of the Am Soc Nephrol, 2008; 3: 281-287
114. Sterling K, Tehrani T, Rudnick M: Clinical significance and preventive strategies for contrast-induced nephropathy. Curr Opin Nephrol Hypertens, 2008; 17
115. Rehman T, Fought J, Solomon R: N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol, 2008; 6: 1610-1614
116. El-Osta A et al: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. JEM, 2008; 205: 2409-2417
117. Fishbane S: N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol, 2008; 1: 281-287
118. Frei B: Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med, 1994; 26: 5S-13S
119. Marenzi G et al: N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med, 2006; 354: 2773-2782 (Pubitemid 43974195)
120. Schlienger RG, Ritz R, Haefeli WE: Clinico-pharmacological case (4): epileptic seizure as an unwanted drug effect on theophylline poisoning [in German]. Schweiz Rundsch Med Prax, 1996; 85: 1407-1412
121. Balakrishnan VS, Williams JD: Effects of intravenous adenosine on renal function in healthy human subjects. Am J Physiol, 1996; 271: F374-81 (Pubitemid 26299003)
122. Teria T, Kita Y: General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo [1,5- a] pyridin-3-yl) acryloyl]-2-piperidine ethanol. Arzneimittelforschung, 1996; 46: 185-191 (Pubitemid 126423358)
123. Kuan CJ, Jackson EK: Cardiovacular and renal effects of blocking A1 adenosine receptors. J Cardiovasc Pharmacol, 1993; 21: 822-828 (Pubitemid 23121883)
124. Maczewski M: The role of adenosine and ATP-sensitive potassium channels in the protection afforded by ischemic preconditioning against the post-ischemic endothelial dysfunction in guinea-pig hearts. J Mol Cell Cardiol, 1998; 30: 1735-1747 (Pubitemid 28430187)
125. Neely CF, Kong M, Greelish JP, Gardner TJ: A1 adenosine receptor antagonists block ischemic-reperfusion injury of the heart. Circulation, 1996; 94(Suppl.9): II376-80 (Pubitemid 26363423)
126. Pfister JR, Lee G: Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl- 8-[2-(5,6-epoxynorbonyl)]-xanthine. J Med Chem, 1997; 40: 1773-1778 (Pubitemid 27251266)
127. Chang L: 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. J Med Chem, 2004; 47(26): 6529-6540 (Pubitemid 39657315)
128. Weyler S: Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido [1,2,3-cd]purinediones. Chem Med Chem, 2006; 1(8): 891-902
129. Xu B, Crist GH, LaNoue KF: A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am J Nephrol, 1998; 274(2, pt 1): E271-79 (Pubitemid 28140811)
130. Agarwal R: Effects of statins on renal function. Mayo Clin Proc, 2007; 82: 1579
131. Khanal S et al: Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med, 2005; 118: 843-849 (Pubitemid 41097461)
132. Schindler R et al: Removal of contrast media by different extra-corporeal treatments. Nephrol Dial Transplant, 2001; 16: 1471-1474 (Pubitemid 32640606)
133. Donnelly P et al: Hemodialysis and iopamidol clearance after subclavian venography. Invest Radiol, 1993; 28: 629-632 (Pubitemid 24088639)
134. Furukawa T, Ueda J, Takahashi S, Sakaguchi K: Elimination of low-osmolality contrast media by hemodialysis. Acta Radiol, 1996; 37: 996-1071 (Pubitemid 126439289)
135. Moon S, Bäck S, Kurkus J, Nilsson-Ehle P: Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron, 1995; 70: 430-437
136. Lehnert T et al: Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant, 1998; 13: 358-362 (Pubitemid 28062196)
137. Sterner G, Frennby B, Kurkus J, Nyman U: Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol, 2000; 34: 323-326
138. Reinecke H et al: A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol, 2007; 96, 130-139 (Pubitemid 46363767)
139. Huber W et al: Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Invest Radiol, 2002; 37: 471-481 (Pubitemid 34966852)
140. Frank H et al: Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy. Clin Nephrol, 2003; 60: 176-182 (Pubitemid 37121780)
141. Vogt B et al: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med, 2001; 111: 692-698 (Pubitemid 34017520)
142. Marenzi G et al: The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration. N Engl J Med, 2003; 349: 1333-1340 (Pubitemid 37186211)
143. Jacobs F: Hemofiltration and the prevention of radiocontrast-agent- induced nephropathy. N Engl J Med, 2004; 19: 836-838
144. Derhaschnig U et al: Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia. Crit Care Med, 2003; 31: 1108-1112 (Pubitemid 36444421)
145. Sela S et al: Oxidative stress during hemodialysis: effect of heparin. Kidney Int, 2001; 78: 159-163 (Pubitemid 32144090)